Ellie Kincaid

Former Iranian government official up to two retractions, five corrections

A lung specialist who has held positions in Iran’s Ministry of Health and National Medical Council now has two retractions and five corrections of his published papers for re-using text.

In the case of the retractions, the re-used text was an entire paper.

Esmaeil Idani (who also spells his last name “Eidani”), now affiliated with Shahid Beheshti University of Medical Sciences in Tehran, is a middle author on two papers retracted for republication, and corrections to two of his papers acknowledge duplicated text with each other and a third paper.

According to an online CV, Idani has worked as “Deputy Secretary of the Medical Education and Training Council” for Iran’s Ministry of Health and Medical Education, and from 2013-2017 was chairman of the Supreme Medical Council of Iran. He has not responded to our request for comment.

How journal editors kept questionable data about women’s health out of the literature years before retractions

In July of 2017, Mohamed Rezk, of the department of obstetrics and gynecology at Menoufia University in Egypt, submitted a manuscript to the journal Anesthesia with a colleague.

The manuscript, “Analgesic and antiemetic effect of Intraperitoneal magnesium sulfate in laparoscopic salpingectomy: a randomized controlled trial,” caught the attention of John Carlisle, an editor at the journal whose name will be familiar to Retraction Watch readers as the sleuth whose statistical analyses have identified hundreds of papers with implausible clinical trial data.

The baseline data appeared unremarkable, Carlisle told us, but the same wasn’t true of the outcomes data. Of 24 values that could have been odd or even numbers, all of them were even.

The probability of that was “0.000000000000000000000 something,” Carlisle said.

Journal sends cease-and-desist letter to a company marketing a homeopathic alternative to opioids

StellaLife’s Vega Oral Care Recovery Kit

Stephen Barrett, a U.S. physician and founder of Quackwatch, makes a point of calling out homeopathy and other health products and practices that lack evidence.

In that vein, earlier this year he emailed the Journal of Oral and Maxillofacial Surgery to critique a 2019 article by Walter Tatch titled “Opioid Prescribing Can Be Reduced in Oral and Maxillofacial Surgery Practice,” which has been cited five times, according to Clarivate’s Web of Science.

Exclusive: NIH researcher resigned amid retractions, including Nature paper

A tenure-track investigator at the National Institute of Environmental Health Sciences (NIEHS), a division of the National Institutes of Health, resigned in March, as questions mounted about her work, Retraction Watch has learned.

Jennifer Martinez has retracted at least two papers, including a 2016 Nature paper with the chair of the immunology department at St. Jude Children’s Research Hospital in Memphis, Tenn., and has another marked with an expression of concern.

The retraction is the first for Douglas R. Green of St. Jude, although he’s had a handful of corrections and two other papers he published in Nature have been questioned by scientists who couldn’t replicate the results.

After a postdoc at St. Jude, Martinez led an independent research program at NIEHS in Research Triangle Park, North Carolina since 2015, according to an online CV. She resigned from NIEHS in March and a federal research watchdog is looking into her work, a spokesperson told us:

Brain tumor researchers retract paper from Science journal

A detail from Fig. 6 of the now-retracted paper

A brain tumor researcher at the University of California, San Francisco, has retracted a paper from Science Translational Medicine, and is a co-author on an article that another journal is examining.

The problems in both papers, and several others with shared authors, came to light via comments on PubPeer by Elisabeth Bik and a pseudonymous commenter.

The Science Translational Medicine paper, “A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells,” was published last May by a group led by Russell O. Pieper, director of basic science in the UCSF Brain Tumor Center and vice-chairman of the UCSF department of neurological surgery. The paper has been cited six times, according to Clarivate’s Web of Science.

Former NCI postdoc faked data, says federal watchdog

A former postdoc at the National Cancer Institute faked 15 figures and a movie in grant applications, presentations, a paper, and an unpublished manuscript, according to a federal watchdog.

The finding from the U.S. Office of Research Integrity (ORI) comes more than a year after PLOS Biology retracted a 2016 paper and noted that the National Institutes of Health (NIH) had found that the postdoc, Ritankar Majumdar, committed misconduct and faked data in two figures.

The same day, the journal republished a revised version without the faked data. The retracted paper has been cited 107 times, 13 of those after it was retracted, according to Clarivate’s Web of Science. The revised paper — which included Majumdar as a first author — has been cited eight times.

The retraction notice stated that Majumdar agreed with the retraction but that he “disputes the NIH’s finding of misconduct.”

Veterinary researcher banned from journal after fourth forthcoming retraction

A veterinary researcher with three retracted papers and one marked with an expression of concern has another retraction on the way, Retraction Watch has learned.

The first retraction for Tereza Cristina Cardoso da Silva, of the University of São Paulo State in Brazil, came in 2019. As we reported at the time, the retracted paper, about herpesvirus infections in cattle, had reused an image from an earlier paper describing experiments with chicken cells. (We would apologize for the headline of that post, but we just couldn’t resist.)

Since then, Cardoso has lost two more papers for similarly reusing images of different species of animals, and had another article flagged with an expression of concern that mentions an institutional investigation into her work which culminated in a “Disciplinary Administrative Procedure.” A fourth retraction is in the works, per an email we were copied on from a journal editor to the whistleblower who identified another image reused between species.

In four years, a psychosocial counselor co-authored seven papers on disparate medical topics. How?

At the end of July, Muttukrishna Sarvananthan noticed something curious in the publications of Chulani Herath, a senior lecturer at the Open University of Sri Lanka in Nawala.

Herath is listed as a middle author on seven papers about various topics in medicine, including heart disease, stroke, and burnout among general practitioners in China.

That struck Sarvananthan, an economist in Sri Lanka, as odd. Herath is a psychosocial counselor, not a physician or expert in medicine. “How could she possibly co-author an article in medical sciences?” he wrote in one email to a journal editor, requesting the editor investigate Herath’s paper as a potential product of a paper mill.

Sarvananthan has written to the editors of the journals that published the following seven papers, requesting they investigate:

Exclusive: Cancer researcher sues med school for retaliation after research misconduct finding

A breast cancer researcher at SUNY Downstate in Brooklyn has sued the university for sex discrimination and retaliation after an institutional investigation found she committed research misconduct.

Stacy Blain, an associate professor in the departments of pediatrics and cell biology at Downstate, has alleged that the university violated the Equal Pay Act by paying her less than her male colleagues; discriminated against her based on her sex since she joined the faculty in 2002, including by conducting multiple investigations into her lab’s work; and used the latest investigation and its finding that she committed research misconduct to retaliate against her for accusing the university of sex discrimination.

From the lawsuit:

How a tweet sparked an investigation that led to a PhD student leaving his program

Leslie McIntosh, like many other denizens of Science Twitter, saw a tweet from a pseudonymous account in mid-March that bemoaned a journal’s lack of action after the owner of the account reported “an obvious case of plagiarism.”

13 months since I reported an obvious case of plagiarism. The paper is still online. Journal gone silent and no longer replying to emails.

Ready to name and shame both authors and the journal.@OpenAcademics @AcademicChatter #academictwitter #sciencetwitter pic.twitter.com/3j1hX9uCiR
— Dr Meming (@Dr_Meming) March 15, 2022

The owner of the account had found a paper that ripped off one by his or her own research group while browsing the literature. “It isnt just sentence copying, the whole structure and concept of the paper is THE SAME,” the account tweeted later in the thread.

McIntosh, CEO and cofounder of Ripeta, a tech company that offers automated tools to assess scientific papers, began looking into the paper and its corresponding author, Mohammed Sahab Uddin.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: